Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
JACC. Cardiovascular Interventions|December 24, 2011
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation insights from the ABSORB B trialSalvatore Brugaletta, Josep Gomez-Lara, Patrick W Serruys, et al.Journal of the American College of Cardiology|November 4, 2017
Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST RegistryKyohei Yamaji, Yasushi Ueki, Geraud Souteyrand, et al.Heart (British Cardiac Society)|April 29, 2026
Derivation and validation of a prediction model for long-term mortality in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the PREDICT-ST-Elevation Myocardial Infarction scoreLuis Ortega-Paz, Claudio Laudani, Salvatore Brugaletta, et al.American Heart Journal|June 6, 2023
Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND studyKamil Bujak, Pablo Vidal-Cales, Rami Gabani, et al.Journal of the American College of Cardiology|March 5, 2021
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial InfarctionSalvatore Brugaletta, Josep Gomez-Lara, Luis Ortega-Paz, et al.JACC. Cardiovascular Interventions|March 22, 2014
Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registriesJose M de la Torre Hernandez, José A Baz Alonso, Joan A Gómez Hospital, et al.JACC. Cardiovascular Interventions|August 25, 2022
Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND TrialRami Gabani, Francesco Spione, Victor Arevalos, et al.Journal of the American Heart Association|November 29, 2022
Impact of Diabetes on 10-Year Outcomes Following ST-Segment-Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND TrialFrancesco Spione, Victor Arevalos, Rami Gabani, et al.European Heart Journal|November 4, 2021
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trialRafael Romaguera, Pablo Salinas, Josep Gomez-Lara, et al.International Journal of Cardiology|September 5, 2025
Benefit of coronary stenting using available intracoronary tools in high-risk patients. The OPTI-XIENCE studyRaul Moreno, Sergio Bravo Baptista, Borja Rivero-Santana, et al.Pageof 8